连续性血液净化在危重症心肾综合征患者中的临床应用

目的探讨连续性血液净化在危重症心肾综合征患者中的临床应用效果。方法选取2011年3月~2013年3月本院收治的危重症心肾综合征患者32例,采用连续性血液净化治疗,比较治疗前后CO2-CP、Na+、K+、Cys-C、hs-CRP、SCr、APACHEⅡ值、SVR、CVP、TFC、CO及尿量。结果治疗前后CO2-CP、Na+、K+、Cys-C、hs-CRP、SCr、APACHEⅡ值、SVR、CVP、TFC、CO及尿量比较差异有统计学意义(P<0.05)。治疗后有28例患者少尿症状得到改善,总有效率为87.5%。结论采用连续性血液净化治疗可改善危重症心肾综合征患者的各项临床症状、肾功能,有效纠正其代谢紊乱,显著提高其抢救的成功率,值得临床推广应用。

Clinical application of continuous blood purification in patients with critical cardiorenal syndrome

Objective To observe clinical application effect of continuous blood purification in patients with critical cardiorenal syndrome.Methods 32 cases with critical cardiorenal syndrome in our hospital from March 2011 to March 2013 were selected.Continuous blood purification was used in all patients.CO2-CP,Na＋,K＋,Cys-C,hs-CRP,SCr,APACHE lI ,SVR,CVP,TFC,CO and urine volume before and after treatment was compared respectively.Results CO2-CP,Na＋,K＋, Cys-C,hs-CRP,SCr, APACHE II ,SVR,CVP,TFC,CO and urine volume before and after treatment was compared respec- tively,with statistical difference（P〈0.05）.After treatment,the oliguria of 28 cases improved,total effective rate was 87.5%. Conclusion Continuous blood purification applied in patients with critical cardiorenal syndrome not only can improve clinical symptoms and renal function,but also can evidently improve success rate of rescue while effectively correcting metabolic disorders,which is worthy of clinical promotion and application.